Animal Eubiotics Market Size, Share & Industry Analysis, By Product (Probiotics, Prebiotics, Organic Acids, Essential Oils, Enzymes), By Livestock (Poultry, Porcine, Aquatic , Others), By Form (Solid, Liquid), By Application (Gut Health, Immunity, Yield, Others) , By Distribution Channel (Veterinary Hospitals & Clinics, Drug Stores & Pharmacies, Others) And Regional Forecast, 2024-2032
KEY MARKET INSIGHTS
Eubiotics are feed additives that are used to maintain the digestive health of livestock, which helps in the growth and maintenance of animal health. Animal eubiotics help in the proper nutrient absorption required for the normal functioning of the animal body. It is essential in the production of well-nourished animals. Eubiotics are substitutes for antibiotics in feed and are better for the overall digestive health of an animal.
The global animal eubiotics market is to witness significant growth, because of the growth in the demand for animal protein, coupled with the increase in the demand for manufactured feed, and the ban of antibiotics.
However, due to various complicated regulatory procedures for the trade of animal livestock and the large financial costs associated with the production of these compounds, the market growth will be hampered in the forecast period.
Key Market Driver -
Increasing awareness about feed quality and safety to drive the market growth.
Key Market Restraint -
Trade complexities due to impositions of regulation coupled with increase in complications in the food production chain.
Market Segmentation:
Globally, the animal eubiotics market can be segmented on the basis of product, livestock, form, application, distribution channel, and region. Based on product, the market can be segmented into probiotic, prebiotic, organic acids, essential oils, and Enzymes. Based on livestock, the market can be segmented into poultry, porcine, aquatic, and others. Based on form, the market can be segmented into solid and liquid. Based on application, the market can be segmented into gut health, immunity, yield, and others. Based on distribution channel, the market can be segmented into veterinary hospitals and clinics, drug stores & pharmacies, and others. Geographically, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Key Players Covered:
The major companies in the global animal eubiotics market report include Cargill, Incorporated, Novozymes, ASAHI GROUP HOLDING, LTD., Lesaffre, BASF SE, DSM, Lallemand Inc., ADDCON GmbH. Chr. Hansen Holding A/S, Kemin Industries, Inc., and prominent players.
Key Insights
- New Product Launches
- Overview of R&D Advances in Animal Eubiotics
- Overview of Animal Population – By Key Countries
- Impact of COVID-19 on the Global Animal Eubiotics Market
- Key Industry Development - Mergers and Acquisitions
Regional Analysis:
Europe is the largest regional segment, this is due to the efforts taken by livestock producers to comply with the regulations and the ban the usage of antibiotics which results in high product demand, which is expected to benefit the market for eubiotics. Presence of key players in the region, robust awareness of the usage of eubiotics and their benefits, and strong demand from key European countries are driving the demand in the region. The Asia Pacific Region is an emerging region, next to Europe as manufacturers are focusing more on this region. These European companies are trying to increase their global footprint by opening offices, manufacturing facilities, and R&D centers. The increasing population in the region and the high disposable income of the people are factors responsible for a rise in meat consumption in the region. Such trends are expected to drive the market for eubiotics in the region.
The Latin America region is also expected to show a substantial growth due to the rise in animal production and increasing awareness among the farmers of this region. The Middle East and Africa region is is a slow growing market. However, the ban of antibiotics in this region has created a new avenue for the eubiotics market.
To gain extensive insights into the market, Request for Customization
Segmentation
ATTRIBUTES | DETAILS |
By Product |
|
By Livestock |
|
By Form |
|
By Application |
|
By Distribution Channel |
|
By Geography |
|
Animal Eubiotics Industry Developments
- In June 2019, DSM announced the launch of “Balancius” which was developed in collaboration with Novozymes.
- In March 2017, Boehringer Ingelheim and Novozymes together announced an agreement and strategic collaboration in probiotics for poultry hatcheries.
- Ongoing
- 2023
- 2019-2022
Personalize this Research
- Granular Research on Specified Regions or Segments
- Companies Profiled based on User Requirement
- Broader Insights Pertaining to a Specific Segment or Region
- Breaking Down Competitive Landscape as per Your Requirement
- Other Specific Requirement on Customization
Healthcare Clients
